Header Logo

Marc Fisher

Concepts (206)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
43
2020
858
8.480
Why?
Brain Ischemia
31
2019
296
7.010
Why?
Neuroprotective Agents
10
2016
55
2.450
Why?
Tissue Plasminogen Activator
7
2016
105
2.120
Why?
Cerebrovascular Circulation
12
2012
120
2.010
Why?
Infarction, Middle Cerebral Artery
7
2009
55
1.970
Why?
Clinical Trials as Topic
15
2016
384
1.970
Why?
Periodicals as Topic
4
2017
163
1.670
Why?
Thrombectomy
3
2019
105
1.610
Why?
Endovascular Procedures
4
2019
332
1.540
Why?
Diffusion Magnetic Resonance Imaging
10
2009
92
1.400
Why?
Thrombolytic Therapy
7
2016
151
1.220
Why?
Editorial Policies
2
2017
49
1.190
Why?
Disease Models, Animal
14
2013
1811
1.060
Why?
Reperfusion Injury
4
2016
50
1.050
Why?
Platelet Aggregation Inhibitors
4
2009
215
1.050
Why?
Fibrinolytic Agents
4
2010
147
1.030
Why?
Ischemic Attack, Transient
4
2018
75
0.940
Why?
Magnetic Resonance Imaging
7
2009
1362
0.860
Why?
Rats
17
2013
1822
0.850
Why?
Time Factors
16
2019
3191
0.790
Why?
Reperfusion
5
2010
25
0.790
Why?
Treatment Outcome
13
2020
3803
0.770
Why?
Drug Design
3
2010
143
0.740
Why?
Decision Support Techniques
1
2019
154
0.680
Why?
Anticoagulants
5
2020
392
0.680
Why?
Animals
31
2016
18040
0.680
Why?
Humans
42
2020
48437
0.620
Why?
Magnetic Resonance Angiography
3
2006
121
0.610
Why?
Health Planning Guidelines
2
2007
26
0.580
Why?
Warfarin
3
2020
101
0.580
Why?
Rats, Sprague-Dawley
11
2008
512
0.560
Why?
Ticlopidine
2
2006
61
0.550
Why?
Granulocyte Colony-Stimulating Factor
2
2013
35
0.510
Why?
Brain
6
2007
1158
0.490
Why?
Acute Disease
8
2010
612
0.470
Why?
Freezing
1
2011
15
0.460
Why?
Recovery of Function
4
2019
185
0.450
Why?
Embolism
2
2008
29
0.430
Why?
Thrombophilia
1
2010
16
0.420
Why?
Brain Injuries
2
2013
123
0.410
Why?
Aspirin
2
2009
175
0.400
Why?
Male
22
2019
23085
0.400
Why?
Cerebral Infarction
2
2007
52
0.390
Why?
Gadolinium
1
2009
54
0.380
Why?
Intracellular Signaling Peptides and Proteins
1
2011
303
0.380
Why?
Intracranial Embolism
1
2009
25
0.380
Why?
Laser-Doppler Flowmetry
1
2008
4
0.380
Why?
Behavior, Animal
2
2007
179
0.370
Why?
Brain Infarction
1
2008
15
0.370
Why?
Hyperoxia
1
2008
12
0.370
Why?
Research
2
2009
187
0.370
Why?
Atrial Fibrillation
3
2020
532
0.370
Why?
Contrast Media
1
2009
284
0.340
Why?
Biomedical Technology
1
2007
5
0.330
Why?
Cerebral Arteries
1
2007
20
0.330
Why?
Rats, Wistar
4
2013
169
0.320
Why?
Telemedicine
2
2009
207
0.310
Why?
Middle Cerebral Artery
1
2006
34
0.300
Why?
Dimethyl Sulfoxide
1
2005
14
0.300
Why?
Membrane Proteins
1
2011
782
0.300
Why?
Drug Evaluation, Preclinical
1
2005
88
0.290
Why?
Device Approval
1
2005
10
0.290
Why?
Diffusion
5
2008
74
0.270
Why?
Cerebral Cortex
1
2005
206
0.260
Why?
Patient Selection
3
2016
341
0.260
Why?
Recombinant Proteins
3
2016
661
0.250
Why?
Research Design
2
2005
523
0.250
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2005
185
0.250
Why?
Stem Cell Transplantation
1
2003
62
0.250
Why?
Heparin, Low-Molecular-Weight
1
2002
24
0.240
Why?
Factor Xa Inhibitors
2
2020
31
0.240
Why?
Neuroimaging
2
2013
74
0.230
Why?
Neurons
2
2011
766
0.230
Why?
Disease Management
1
2003
178
0.230
Why?
Heparin
1
2002
106
0.230
Why?
Blood Pressure
3
2010
467
0.220
Why?
Aged, 80 and over
5
2020
4206
0.220
Why?
Astrocytes
1
2002
93
0.220
Why?
Risk Factors
4
2019
4186
0.210
Why?
Drug Therapy, Combination
3
2009
373
0.210
Why?
Tomography, X-Ray Computed
1
2006
1057
0.200
Why?
China
1
2019
109
0.190
Why?
Rivaroxaban
1
2018
13
0.190
Why?
Risk Assessment
2
2019
1573
0.190
Why?
Dabigatran
1
2018
17
0.180
Why?
Aged
6
2020
10791
0.180
Why?
Disability Evaluation
1
2019
183
0.180
Why?
Regional Blood Flow
2
2008
93
0.170
Why?
Hemorrhage
3
2019
218
0.170
Why?
Homes for the Aged
1
2019
147
0.170
Why?
Nursing Homes
2
2020
531
0.160
Why?
Predictive Value of Tests
1
2019
831
0.160
Why?
Secondary Prevention
3
2018
123
0.160
Why?
Neurology
1
2016
23
0.160
Why?
Protein C
1
2016
28
0.160
Why?
Registries
1
2019
648
0.160
Why?
Health Services Needs and Demand
1
2017
189
0.150
Why?
Middle Aged
4
2019
13421
0.150
Why?
Clinical Protocols
1
2016
123
0.150
Why?
Reproducibility of Results
1
2019
1311
0.150
Why?
Retrospective Studies
3
2020
4390
0.140
Why?
Randomized Controlled Trials as Topic
2
2009
482
0.140
Why?
United States
5
2020
6085
0.130
Why?
Injections, Intravenous
2
2005
140
0.130
Why?
Cerebral Hemorrhage
2
2005
58
0.130
Why?
Diagnostic Imaging
2
2008
200
0.130
Why?
Practice Patterns, Physicians'
1
2019
680
0.120
Why?
Health Services Accessibility
1
2017
429
0.120
Why?
Language
1
2014
115
0.120
Why?
Tetrazolium Salts
2
2008
14
0.110
Why?
Cognition Disorders
1
2013
211
0.110
Why?
Disks Large Homolog 4 Protein
1
2011
18
0.110
Why?
Medicare
3
2020
437
0.110
Why?
Vascular Surgical Procedures
1
2013
212
0.110
Why?
Factor V Deficiency
1
2010
1
0.110
Why?
Antithrombin III Deficiency
1
2010
2
0.110
Why?
Protein S Deficiency
1
2010
2
0.110
Why?
Protein C Deficiency
1
2010
3
0.110
Why?
Female
5
2019
26169
0.110
Why?
Foramen Ovale, Patent
1
2010
11
0.110
Why?
Cell Death
1
2011
243
0.100
Why?
Cortical Spreading Depression
1
2009
9
0.100
Why?
Cost-Benefit Analysis
1
2010
227
0.100
Why?
Hospital Units
1
2009
9
0.100
Why?
Health Care Sector
1
2009
20
0.090
Why?
Magnetic Field Therapy
1
2008
2
0.090
Why?
Infusions, Intra-Arterial
1
2008
9
0.090
Why?
Image Processing, Computer-Assisted
3
2007
532
0.090
Why?
Administration, Oral
2
2020
299
0.090
Why?
Functional Laterality
2
2006
120
0.090
Why?
Species Specificity
1
2009
324
0.090
Why?
Infusions, Intravenous
1
2008
157
0.090
Why?
Drug Administration Schedule
1
2008
255
0.090
Why?
Guidelines as Topic
1
2009
147
0.090
Why?
Blood Glucose
1
2010
446
0.090
Why?
Radiography
2
2006
338
0.090
Why?
Case-Control Studies
1
2010
882
0.090
Why?
Peptides
1
2011
502
0.090
Why?
Equipment Design
1
2008
273
0.080
Why?
Injury Severity Score
1
2007
75
0.080
Why?
Virginia
1
2007
13
0.080
Why?
Electrocardiography
1
2009
357
0.080
Why?
Practice Guidelines as Topic
1
2010
596
0.080
Why?
Cells, Cultured
1
2011
2084
0.080
Why?
Benzenesulfonates
1
2006
15
0.080
Why?
Brain Mapping
1
2007
187
0.080
Why?
Rats, Inbred WKY
1
2005
10
0.070
Why?
Body Temperature
1
2005
44
0.070
Why?
Drug Industry
1
2005
36
0.070
Why?
Legislation, Drug
1
2005
15
0.070
Why?
Equipment Safety
1
2005
16
0.070
Why?
Product Surveillance, Postmarketing
1
2005
17
0.070
Why?
Carbon Dioxide
1
2005
64
0.070
Why?
Cerebrovascular Disorders
1
2005
61
0.070
Why?
Drug Approval
1
2005
25
0.070
Why?
Models, Animal
1
2005
201
0.070
Why?
United States Food and Drug Administration
1
2005
81
0.070
Why?
Risk
1
2005
367
0.070
Why?
Software
1
2007
324
0.070
Why?
Heart Rate
1
2005
260
0.070
Why?
Aspirin, Dipyridamole Drug Combination
1
2003
3
0.070
Why?
Regression Analysis
1
2005
466
0.070
Why?
Dipyridamole
1
2003
22
0.070
Why?
Cohort Studies
2
2020
2044
0.060
Why?
Quality of Health Care
1
2008
470
0.060
Why?
Recurrence
1
2005
494
0.060
Why?
Hydrogen-Ion Concentration
1
2005
407
0.060
Why?
Oxygen
1
2005
239
0.060
Why?
Thrombosis
1
2006
187
0.060
Why?
Drug Combinations
1
2003
121
0.060
Why?
Pharmaceutical Preparations
1
2005
109
0.060
Why?
Odds Ratio
1
2005
760
0.060
Why?
Drug Synergism
1
2003
124
0.060
Why?
Adult
2
2009
13156
0.060
Why?
Multivariate Analysis
1
2005
854
0.060
Why?
Treatment Failure
1
2003
166
0.060
Why?
Combined Modality Therapy
1
2003
302
0.060
Why?
Disease Progression
1
2005
706
0.060
Why?
Microscopy, Electron
1
2002
248
0.060
Why?
Decision Making
1
2004
319
0.050
Why?
Severity of Illness Index
1
2005
1159
0.050
Why?
Prospective Studies
1
2007
2472
0.050
Why?
Water
1
2002
255
0.050
Why?
Follow-Up Studies
1
2005
1926
0.050
Why?
Drug Substitution
1
2019
32
0.050
Why?
Algorithms
1
2004
881
0.050
Why?
Intracranial Hemorrhages
1
2018
36
0.050
Why?
Thromboembolism
1
2018
57
0.050
Why?
Mice
1
2011
9155
0.040
Why?
Health Care Surveys
1
2019
260
0.040
Why?
Skilled Nursing Facilities
1
2018
75
0.040
Why?
Urbanization
1
2017
2
0.040
Why?
Drug Utilization
1
2019
221
0.040
Why?
Proportional Hazards Models
1
2018
633
0.040
Why?
Nursing Staff, Hospital
1
2017
60
0.040
Why?
Mechanical Thrombolysis
1
2016
29
0.040
Why?
Double-Blind Method
1
2016
552
0.040
Why?
Area Under Curve
1
2013
108
0.030
Why?
Cross-Sectional Studies
1
2019
2023
0.030
Why?
Neuropsychological Tests
1
2013
300
0.030
Why?
Myocardial Infarction
1
2018
834
0.030
Why?
Silicon
1
2006
16
0.020
Why?
Sutures
1
2006
35
0.020
Why?
Perfusion
1
2006
106
0.020
Why?
Surface Properties
1
2006
248
0.020
Why?
Fisher's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (206)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_